Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Recommends New Measures For JAK Inhibitors After Confirming Serious Risks
Oct 28 2022
•
By
Neena Brizmohun
The EMA has been exploring side effects associated with certain JAK inhibitors • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography